Y-mAbs Therapeutics, Inc. - COM (YMAB)

Historical Portfolio Holders from Q3 2018 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
25.7M
Holdings value Q3 2024
$339M
Value change Q3 2024
+$17.3M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
105
Number of buys Q3 2024
55
Number of sells Q3 2024
-36
Average buys Q3 2024 %
+0.001%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 25.7M $339M +$17.3M $13.15 105
2024 Q2 24.4M $294M +$14.9M $12.08 95
2024 Q1 23M $374M +$49.1M $16.26 94
2023 Q4 18M $123M +$5.16M $6.82 92
2023 Q3 19.7M $107M +$812K $5.45 98
2023 Q2 19.5M $132M +$4.78M $6.79 95
2023 Q1 19M $95.4M -$1.13M $5.01 84
2022 Q4 19.3M $94.2M -$55.2M $4.88 89
2022 Q3 23.6M $340M -$17.9M $14.42 95
2022 Q2 24.8M $375M -$7.49M $15.13 91
2022 Q1 25.3M $301M -$14.8M $11.88 87
2021 Q4 25.7M $417M -$24.2M $16.21 93
2021 Q3 26.2M $749M -$2.98M $28.54 95
2021 Q2 26.1M $887M -$1.16M $33.80 98
2021 Q1 26.3M $796M +$116M $30.24 115
2020 Q4 22.8M $1.13B +$37.9M $49.51 114
2020 Q3 21.4M $823M +$3.02M $38.39 105
2020 Q2 21.3M $920M +$53.4M $43.20 108
2020 Q1 20.1M $522M +$16M $26.10 80
2019 Q4 19.4M $606M +$185M $31.25 81
2019 Q3 13.1M $342M +$56.5M $26.06 65
2019 Q2 11M $251M +$54.3M $22.87 59
2019 Q1 8.48M $222M -$3.12M $26.21 44
2018 Q4 8.69M $176M +$18.7M $20.34 42
2018 Q3 7.73M $205M +$205M $26.56 38